- Lobbying
- Kristen AND Bautz
Lobbying Arrangements Results for 'Kristen Bautz'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details US global competitiveness issues and taxation rates; R&D tax credits |
Silicon Valley Tax Directors Group
|
H&M STRATEGIES LLP | |||
Details EQUAL Act (S. 524/HR 1062); prison oversight issues and the Prison Oversight Act (HR 3019) and S 1401 |
Families Against Mandatory Minimums (FAMM)
|
H&M STRATEGIES LLP | |||
Details Assistance in contacting the federal government regarding healthcare issues specifically medicare advantage reimbursements and designation requirements. monitor healthcare legislation and changes. ... |
Central Florida Health Alliance
|
Cardenas Partners, LLC | |||
Details National Flood Insurance Program issues and reauthorization; FEMA issues FEMA mapping issues home building code issues and updated guidance (2021 IECC); FEMA LOMR issues general issues pertaining t... |
National Association of Home Builders
|
H&M STRATEGIES LLP | |||
Details Assistance in contacting the federal government and related agencies regarding education issues that affect the clients interests as well as seeking funding opportunities for public charter schools. |
Florida Consortium of Public Charter Schools
|
Cardenas Partners, LLC | |||
Details issues pertaining to online hate speech, Anti Semitism and human rights draft legislation pertaining to online threat assessments and information dissemination |
Anti-Defamation League (ADL)
|
H&M STRATEGIES LLP | |||
Details Issues related to the organ donation system and the organ procurement transplantation network. |
Organize Action Network
|
Farragut Partners LLP | |||
Details Tax issues impacting advanced silicon chip technologies, including R&D Trade issues, including export controls US/China trade relationship |
Synopsys
Silicon chip design company |
H&M STRATEGIES LLP | |||
Details General Healthcare issues, drug pricing legislation and issues related to chemotherapy Induced Neutropenia |
BeyondSpring Inc.
|
Farragut Partners LLP | |||
Details Issues relating to the coverage of treatments for iron deficiency anemia. |
AMAG Pharmaceuticals, Inc.
|
Farragut Partners LLP | |||
Details Issues Related to a COVID-19 Vaccine. Monitoring Vaccine legislation. Drug pricing. |
Novavax, Inc.
|
Farragut Partners LLP | |||
Details Issues relating to the coverage of treatments for iron deficiency anemia |
Daiichi Sankyo Inc
|
Farragut Partners LLP | |||
Details Issues related to coverage of peripheral nerve stimulation |
SPR Therapeutics
|
Farragut Partners LLP | |||
Details Issues related to secure modifications act, ports and vaccines. Issues related to clean water |
NantWorks
|
Farragut Partners LLP | |||
Details Coverage and reimbursement policy for medical devices/THV Medicare coverage of breakthrough therapies Policies promoting medical innovation. Coverage with evidence development. 21st Century Cures 2.0 |
Edwards Lifesciences, LLC
|
Farragut Partners LLP | |||
Details issues pertaining to autonomous vehicle technology and AV trucking; draft AV legislation issues pertaining to the development of AV technology and deployment; draft legislation relating to AV testi... |
Aurora Innovation, Inc.
|
H&M STRATEGIES LLP | |||
Details General representation. Regulations and legislation relating to PBMs and drug pricing. Issues related to the 340B drug discount program |
Pharmaceutical Research and Manufacturers of America
|
Farragut Partners LLP | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmac... |
OneOncology Inc.
|
Farragut Partners LLP | |||
Details Issues related to coverage policy for Medicare reimbursement of breast reconstruction surgery |
Elisabeth Potter MD PLLC
|
Farragut Partners LLP | |||
Details Issues related to the organ donation system and the organ procurement transplantation network. |
Organize
Patient Advocacy Network |
Farragut Partners LLP | |||
Details Coverage and reimbursement policy for HCV and HIV portfolios. Issues pertaining to the six protected classes. Drug pricing legislation- part D redesign. Issues related to Medicaid drug rebate progr... |
Gilead Sciences Inc.
|
Farragut Partners LLP | |||
Details Issues related to user fee reauthorization. Legislative efforts related to the FIND Act (H.R.4479) (S.2609) |
Lantheus Medical Imaging, Inc.
|
Farragut Partners LLP | |||
Details issues pertaining to online music streaming and speech/content moderation issues related to online data use and privacy and ad-supported business models and the American Data Privacy Protection Act... |
Spotify
|
H&M STRATEGIES LLP | |||
Details Issues related to the 340B drug discount program. Medicare Part B. Biosimilar Legislation. Drug pricing legislation. Issues related to ASP reporting. Issues related to patient safety in attorney ad... |
Johnson & Johnson Services, Inc.
|
Farragut Partners LLP | |||
Details Issues related to OB/GYN healthcare providers. Issues relating to alternative payment models. Issues relating to maternal health |
U.S. Women's Health Alliance
|
Farragut Partners LLP | |||
Details Issues regarding Medicare payment policies for Part B drugs. Issues related to the 340B Drug discount program. Drug Pricing Proposals. CMMI Guardrails. Issues related to drug pricing (IPI, Part B r... |
Genentech
|
Farragut Partners LLP | |||
Details Issues related to non-opioid alternatives reimbursement. Coverage decisions related to anti nausea treatments. Federal non-opioid directive legislation |
Heron Therapeutics, Inc.
|
Farragut Partners LLP | |||
Details general issues pertaining to online content moderation and Sec 230 of the Communications Decency Act general issues pertaining to autonomous vehicle technology development, artificial intelligence,... |
Consumer Technology Association
|
H&M STRATEGIES LLP | |||
Details supply chain issues impacting the auto industry, including critical minerals for EVs; PART Act (HR 621/S 154); electrification of vehicles; right to repair issues and the SMART Act (HR 1707) and th... |
Toyota
|
H&M STRATEGIES LLP | |||
Details general issues pertaining to safe online products and transparency of online marketplaces; implentation of the INFORM Act as passed by Congress; SHOP SAFE Act (S 2934) 1099 tax reform legislative p... |
Etsy, Inc.
|
H&M STRATEGIES LLP | |||
Details issues pertaining to implementation of the CHIPS and Science Act and manufacturing of semiconductor chips issues pertaining to implementation of the CHIPS and Science Act and the development of the... |
Intel Corp
|
H&M STRATEGIES LLP | |||
Details Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legi... |
Community Oncology Alliance
|
Farragut Partners LLP | |||
Details Issues related to online advertising and consumer privacy reform legislation and policies, including the American Data Privacy and Protection Act (no bill number). Issues related to online publishi... |
Yahoo Inc, and var. subs/affiliates (FKA College Parent, L.P. DBA "Yahoo")
|
H&M STRATEGIES LLP | |||
Details General Representation related to telecommunications legislation and regulation. Privacy issues relating to the gathering, retention, and use of online information. General Representation related t... |
DIRECTV
|
Farragut Partners LLP |